Table 3.
Posaconazole trough plasma levels by category
Number | Median (Range) | Number | Median (Range) | p value | |
---|---|---|---|---|---|
Female | Male | ||||
D2 H0 | 9 | 200 (140–660) | 9 | 290 (120–770) | 0.86 |
D4 H0 | 10 | 300 (140–1820) | 8 | 580 (260–1090) | 0.04 |
D10 H0 | 7 | 770(140–2450) | 6 | 800 (370–1690) | 0.84 |
BSA<1.9m2 | BSA>1.9m2 | ||||
D2 H0 | 8 | 380 (170–660) | 10 | 190 (120–770) | 0.27 |
D4 H0 | 9 | 290 (140–1820) | 9 | 420 (250–1090) | 0.22 |
D10 H0 | 7 | 810 (380–2450) | 6 | 500 (140– 1690) | 0.23 |
No IFI | IFI | ||||
D2 H0 | 13 | 350(140–770) | 5 | 170 (120–270) | 0.08 |
D4 H0 | 14 | 410 (200–1820) | 4 | 310 (140–470) | 0.19 |
D10 H0 | 11 | 810 (140–2450) | 2 | 640 (510–770) | 0.77 |
No G3/4 LFT abnormalities | LFT abnormalities | ||||
D2 H0 | 15 | 200 (140–770) | 3 | 270 (120–490) | 0.74 |
D4 H0 | 16 | 410 (140–1820) | 2 | 270 (250–290) | 0.21 |
D10 H0 | 11 | 540 (140–2450) | 2 | 980 (770–1180) | 0.64 |
Plasma posaconazole levels presented as ng/ml.
D, day; H, hour; BSA, body surface area; IFI, invasive fungal infection; G, grade; LFT, liver function test